A 52-week, open label, parallel group, multicentre, phase III, randomised controlled trial to compare the efficacy and safety of salbutamol metered dose inhaler taken as required for relief of symptoms, and budesonide/formoterol Turbuhaler taken as required for relief of symptoms, and regular budesonide Turbuhaler plus salbutamol metered dose inhaler taken as required for relief of symptoms, in adult patients with asthma.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 20 Sep 2017
At a glance
- Drugs Budesonide/formoterol (Primary) ; Budesonide; Salbutamol
- Indications Asthma
- Focus Therapeutic Use
- Acronyms Novel START
- 18 Sep 2017 Planned End Date changed from 30 Sep 2017 to 30 Aug 2018.
- 18 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 20 Apr 2016 Status changed from not yet recruiting to recruiting.